Ajim Tamboli is an experienced finance professional in the biotechnology sector, holding the position of Chief Financial Officer at several companies, including ADARx Pharmaceuticals Inc., Arbor Biotechnologies, Monte Rosa Therapeutics, and Rodin Therapeutics. Additionally, Ajim has served as an Investor at Asymmetry Capital Management, L.P. Ajim Tamboli's academic qualifications include a Master of Science in Molecular Biology and a Bachelor of Science in Biomedical Science and Economics, both obtained from the University of Pennsylvania.
July, 2024 - present